Back to LLY Stock Lookup
Pages: 1 2 3 »» Last Page

LLY – Analyst Ratings

Apr 14, 2014 07:03 AM Jefferies Upgrades Eli Lilly (LLY) to Hold
Apr 8, 2014 06:51 AM BMO Capital Upgrades Eli Lilly (LLY) to Market Perform
Apr 3, 2014 07:03 AM Cowen Upgrades Eli Lilly (LLY) to Outperform
Feb 19, 2014 10:09 AM Eli Lilly (LLY) Ramucirumab Data a Positive for Dyax (DYAX), Needham & Company Says
Jan 21, 2014 01:15 PM U.S. Large Cap and Specialty Pharma Q4 Previewed at UBS (PFE) (ACT) (MYL)
Jan 10, 2014 07:30 AM Barclays Downgrades Eli Lilly (LLY) to Underweight
Jan 8, 2014 07:09 AM BMO Capital Downgrades Eli Lilly (LLY) to Underperform
Nov 11, 2013 07:01 AM Eli Lilly (LLY) Cut to Sell at Goldman Sachs
Oct 24, 2013 07:58 AM MKM Partners Upgrades Eli Lilly (LLY) to Buy
Oct 11, 2013 07:55 AM Jefferies Downgrades Eli Lilly (LLY) to Underperform
Oct 10, 2013 06:45 AM Edward Jones Upgrades Eli Lilly (LLY) to Hold
Oct 8, 2013 04:53 PM Credit Suisse Starts Eli Lilly (LLY) at Neutral
Sep 26, 2013 11:26 AM Eli Lilly (LLY) Target Lowered to $54 at Goldman
Aug 13, 2013 09:13 AM Lilly's (LLY) Newest Lung Cancer Drug May Have $1.5B/yr Potential
Jun 26, 2013 08:52 AM MannKind (MNKD) Price Target Raised to $8.40 at Piper
May 29, 2013 04:43 PM SunTrust Robinson Humphrey Starts Eli Lilly (LLY) at Buy
May 28, 2013 08:34 AM Jefferies Boosts Price Targets Accross Pharmaceuticals Sector (ABT) (JNJ) (BMY) (more...)
May 28, 2013 07:27 AM Jefferies Upgrades Eli Lilly (LLY) to Hold
Apr 24, 2013 01:15 PM Analyst Encouraged by Eli Lilly (LLY) Cost Containment Efforts
Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
Mar 13, 2013 10:19 AM Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza
Jan 17, 2013 07:57 AM CLSA Starts Eli Lilly (LLY) at Sell
Nov 30, 2012 07:57 AM Citi Starts Eli Lilly (LLY) at Buy
Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis
Oct 15, 2012 11:28 AM Leerink Swann Upgrades Eli Lilly (LLY) to Outperform Following Solid Ramucirumab New
Oct 12, 2012 07:09 AM Cowen Downgrades Eli Lilly (LLY) to Underperform
Oct 9, 2012 11:39 AM Eli Lilly (LLY) Higher on Alzheimer Drug Hopes, Though Results Fail to Impress Analysts
Oct 9, 2012 07:25 AM Goldman Sachs Downgrades Johnson & Johnson (JNJ) to Sell, Sees Limited Upside
Oct 9, 2012 07:01 AM Goldman Sachs Upgrades Eli Lilly (LLY) to Neutral on New "Hope Trade"
Sep 12, 2012 07:52 AM Jefferies on Pharmaceutical: Top Picks Still ABT and NVS
Sep 5, 2012 07:37 AM Bernstein Upgrades Eli Lilly (LLY) to Outperform
Aug 28, 2012 08:02 AM Atlantic Equities Upgrades Eli Lilly (LLY) Two-Notches to Overweight
Aug 27, 2012 01:20 PM Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Review of Solanezumab Results
Aug 27, 2012 10:49 AM UBS Maintains a 'Neutral' on Eli Lilly (LLY); TRILOGY ACS Fails
Aug 24, 2012 02:14 PM Credit Suisse Upgrades Eli Lilly (LLY) to Outperform
Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM
Jul 30, 2012 10:19 AM Jefferies Downgrades Eli Lilly (LLY) to Underperform; Expect Sola Fail
Jul 26, 2012 11:05 AM MKM Partners Raises Numbers on Eli Lilly (LLY); Getting More Constructive
Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say
Jul 18, 2012 10:50 AM Needham & Company Q2 Preview on Cubist Pharmaceuticals (CBST); Cubicin Sales Estimate is $195M
Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?
Jun 22, 2012 03:34 PM Barclays Reiterates an 'Underweight' on Novo Nordisk (NVO); Shares Trading As If Not Risk Priced In
Jun 12, 2012 05:44 PM Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Jun 11, 2012 05:17 PM Barclays on Global Biopharma Stocks: American Diabetes Association 2012: Highlights From GSK, LLY, SNY, NVO & JNJ
May 18, 2012 08:11 AM BMO Capital Starts Eli Lilly (LLY) at Market Perform
May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
Mar 19, 2012 01:37 PM Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Takeaways From Meeting with Mgmt
Mar 2, 2012 08:12 AM JPMorgan Upgrades Eli Lilly (LLY) to Neutral
Feb 14, 2012 08:22 AM ISI Group Starts Eli Lilly (LLY) at Hold
Jan 30, 2012 01:17 PM Q4 Preview: Pfizer (PFE) May Suffer Same Ailment as Peers: Strong Dollar Syndrome
Pages: 1 2 3 »» Last Page

Back to LLY Stock Lookup